Biotech Values

[Preciouslife1]

Bavituximab, is a chimeric monoclonal antibody which is non discriminatory when infused into the human genome, and as a whistleblower to the immune system to instill an immune response from macrophage upon the exposed PS, phosphatydeserine whereas viral and cancerous cells become "flagged" for immune response ....

Bavituximab binds to phosphatidylserine which is exposed on the surface of certain atypical animal cells, including tumour cells and cells infected with any of six different families of virus. These viral families contain the viruses hepatitis C, influenza A and B, HIV 1 and 2, measles, respiratory syncytial virus and pichinde virus, which is a model for the deadly Lassa virus. Other cells are not affected since phosphatidylserine normally is only intracellular.
Bavituximab binds to various aminophospholipids and is dependent on interaction with plasma protein beta-2 glycoprotein I to mediate binding.
These target aminophospholipids, usually residing only on the inner leaflet of the plasma membrane of cells, become exposed in virally infected, damaged or malignant cells, and more generally in most cells undergoing the process of apoptosis.
The antibody's binding to phospholipids alerts the body’s immune system to attack the tumor endothelial cells, thrombosing the tumor's vascular network and/or attacking free floating virally infected and metastatic cells while potentially minimizing side effects in healthy tissues...

It is an indigenous natural occuring monoclonal antibody btw ...

.... And PS ... My lifelong friend was the first person infused with chimeric bavi at the Godofsky Ceneter here in Sarasota Florida, for his severe HCV infection, and within short period of time, was healthy, back in the gym, jaunicide gone, and he is over 200 lbs again ... But he is unable to speak about it due to confidentiality papers signed prior to his inclusion and then infusions ... Mark ...